Taylor Frigon Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.26M Buy
33,522
+5
+0% +$333 1.06% 42
2026
Q1
$2.1M Sell
33,517
-261
-0.8% -$18.2K 1.2% 33
2025
Q4
$2.24M Buy
33,778
+7,937
+31% +$513K 1.13% 36
2025
Q3
$1.74M Sell
25,841
-928
-3% -$73.4K 0.86% 59
2025
Q2
$2.34M Sell
26,769
-1,697
-6% -$133K 1.24% 34
2025
Q1
$1.94M Sell
28,466
-594
-2% -$48.5K 1.16% 39
2024
Q4
$2.26M Sell
29,060
-3,494
-11% -$259K 1.14% 35
2024
Q3
$2.18M Buy
32,554
+11,075
+52% +$909K 1.09% 40
2024
Q2
$2.44M Buy
+21,479
New +$2.72M 1.16% 30

Other funds holding DXCM

Taylor Frigon Capital Management's DXCM Position: Q2 2026 in Review

Taylor Frigon Capital Management increased its DexCom (DXCM) stake by 0.01% in Q2 2026, buying an estimated $333 and bringing the position to 33,522 shares worth $2.26M. The position accounts for 1.06% of the portfolio, ranked #42.

Taylor Frigon Capital Management first reported a position in DXCM in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.44M in Q2 2024. 274 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Taylor Frigon Capital Management held 33,522 shares of DexCom worth $2.26M as of Q2 2026.
  • Taylor Frigon Capital Management bought 5 DexCom shares in Q2 2026, an estimated $333.
  • DexCom made up 1.06% of Taylor Frigon Capital Management's portfolio in Q2 2026, its #42 holding.
  • Taylor Frigon Capital Management first reported a position in DexCom in Q2 2024 and has held it in 9 quarters since.
  • Taylor Frigon Capital Management's DexCom position peaked at $2.44M in Q2 2024.
  • 274 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Taylor Frigon Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.